Home » Topics » Regulatory » Patents

Patents
RSS

Medshine Discovery patents nitroimidazole derivatives

Feb. 6, 2018

Lilly identifies new JAK1 inhibitors

Feb. 6, 2018

PTGDR2 antagonists patented by Jiangsu Chia Tai Tianqing Pharmaceutical, Medshine Discovery

Feb. 5, 2018

Latvian Institute of Organic Synthesis presents seleopheno[h]chromene derivatives

Feb. 5, 2018

Novel beta-glucuronidase inhibitors patented by UNC Chapel Hill

Feb. 5, 2018

Amgen discovers new sodium channel blockers

Feb. 5, 2018

Takeda describes novel Toll-like receptor 4 antagonists

Feb. 5, 2018

Roche presents new compounds for HBV

Feb. 2, 2018

Crinetics Pharmaceuticals identifies new somatostatin SST2 receptor agonists

Feb. 2, 2018

Aduro BioTech and Novartis patent STING-agonists

Feb. 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...